Presentations and Outcomes of Acute Pancreatitis
Clinical Presentations and Outcomes in Patients With Acute Pancreatitis at Al-Rajhi University Hospital-Prospective Study
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Evaluate the outcomes of the patients and their possible predictors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 4, 2026
CompletedFirst Posted
Study publicly available on registry
August 10, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
Study Completion
Last participant's last visit for all outcomes
October 1, 2027
August 10, 2026
August 1, 2026
1 year
August 4, 2026
August 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Frequency and types of clinical patterns of acute pancreatitis and the fates of patients.
july 2026-july 2027
Interventions
arterial blood gases
Eligibility Criteria
All enrolled patients will undergo: * Detailed medical history taking including demographic data, comorbidities, smoking, alcohol intake, and possible etiological factors. * Complete clinical examination. * Laboratory investigations including CBC, liver function tests, kidney function tests, serum amylase, serum lipase, calcium profile, lipid profile, and CRP. * Radiological investigations including abdominal ultrasonography and CT abdomen when indicated. * Assessment of severity using Ranson score, APACHE II score and Revised Atlanta classification. * Follow-up during admission for complications, ICU admission, length of hospital stay, and mortality.
You may qualify if:
- \. Adult patients aged 18 years or older. 2. Patients fulfilling at least two diagnostic criteria of acute pancreatitis. 3. Patients willing to participate in the study.
You may not qualify if:
- Patients with chronic pancreatitis.
- Patients diagnosed with pancreatic malignancy.
- Patients less than 18 years old.
- Patients with incomplete clinical data.
- Refusal to participate. -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
- Petrov MS, Yadav D. Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol. 2019;16(3):175-184.
- Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guidelineManagement of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400-1415.
- . Szatmary P, Grammatikopoulos T, Cai W, et al. Acute pancreatitis: Diagnosis and treatment. Drugs. 2022;82(12):1251-1276.
- Ranson JH, Rifkind KM, Roses DF, et al. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet. 1974;139(1):69-81.
- Papachristou GI, Muddana V, Yadav D, et al. Comparison of BISAP, Ranson's, APACHE II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. Am J Gastroenterol. 2010;105(2):435-441.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Rasha H shehata, assistant professor
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
August 4, 2026
First Posted
August 10, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
October 1, 2027
Last Updated
August 10, 2026
Record last verified: 2026-08